Loading...
Response Assessment in Neuro-Oncology Clinical Trials
Development of novel therapies for CNS tumors requires reliable assessment of response and progression. This requirement has been particularly challenging in neuro-oncology for which contrast enhancement serves as an imperfect surrogate for tumor volume and is influenced by agents that affect vascul...
Na minha lista:
| Udgivet i: | J Clin Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5516482/ https://ncbi.nlm.nih.gov/pubmed/28640707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.72.7511 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|